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Abstract  
We examined the effects of inspiratory muscle training (IMT) upon volitional 
hyperpnoea-mediated increases in blood lactate ([lac
-
]B) during cycling at maximal 
lactate steady state (MLSS) power, and blood lactate and oxygen uptake kinetics at the 
onset of exercise. Twenty males formed either an IMT (n=10) or control group (n=10). 
Before and after a 6-wk intervention two 30 min trials were performed at MLSS (207  
28 W), which was determined using repeated 30 min constant power trials. The first 
was a reference trial, whereas during the second trial from 20-28 min participants 
mimicked the breathing pattern commensurate with 90% of the maximal minute 
ventilation ( EV
 ) measured during maximal incremental exercise. Before the 
intervention the MLSS [lac
-
]B was 3.7  1.8 and 3.9  1.6 mmol·L
-1
 in the IMT and 
control group, respectively. During volitional hyperpnoea EV
  increased from 79.9  9.5 
and 76.3  15.4 Lmin-1 at 20 min to 137.8  15.2 and 135.0  19.7 Lmin-1 in IMT and 
control groups, respectively; [lac
-
]B  commensurately increased by 1.0   0.6 (+27%) 
and 0.9  0.7 mmol·L-1 (+25%), respectively (P<0.05). Maximal inspiratory mouth 
pressure increased 19% following IMT (P<0.01). Following IMT only increases in [lac
-
]B during volitional hyperpnoea were abolished (P<0.05) and reductions were observed 
in the blood lactate (-28%) and phase II oxygen uptake (-31%) time constants at the 
onset of exercise and the MLSS [lac
-
]B (-15%) (P<0.05). We attribute these changes to 
IMT-mediated increases in the oxidative and/or lactate transport capacity of the 
inspiratory muscles.  
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Introduction 
Recently it has emerged that respiratory muscle activity may strongly influence the 
systemic blood lactate concentration ([lac
-
]B) (Brown et al. 2008, 2010; Chiappa et al. 
2009; Johnson et al. 2006; Renggli et al. 2008; Verges et al. 2007). This notion 
contradicts the traditional view that the small mass of the respiratory muscles (estimated 
at around 960 g (Freedman et al. 1983)) and their large oxidative capacity precludes any 
systemically relevant lactate exchange (Wetter and Dempsey 2000). However, a 
significant influence of respiratory muscle activity on [lac
-
]B is supported by three lines 
of evidence. Firstly, a lower (~1.0 mmolL-1) [lac-]B has been observed during whole-
body exercise following pressure-threshold inspiratory muscle training (IMT, a 
strength-training stimulus) (McConnell and Sharpe 2005; Romer et al. 2002b) and 
volitional isocapnic hyperpnoea training (endurance-training stimulus) (Leddy et al. 
2007; Spengler et al. 1999), with up to 52% of variation in post-training whole-body 
exercise performance improvement accounted for by the reduced [lac
-
]B (Romer et al. 
2002b).  
 
Secondly, Chiappa et al. (2009) showed that increasing the work of breathing (via 
pressure-threshold loading) during recovery from maximal exercise significantly 
accelerated rates of lactate clearance and improved subsequent 30 s maximal cycling 
performance. The authors suggest that with loading, the inspiratory muscles are capable 
of net lactate consumption. In support of this notion, we recently demonstrated 
accelerated lactate recovery kinetics and increased lactate clearance when loading 
trained (IMT) inspiratory muscles following maximal exercise (Brown et al. 2010). 
 
Thirdly, 10 min of volitional isocapnic hyperpnoea performed at rest typically results in 
a twofold increase in [lac
-
]B (Brown et al. 2008; Verges et al. 2007), which is 
subsequently attenuated following IMT (Brown et al. 2008) and volitional isocapnic 
hyperpnoea training (Verges et al. 2007). Presumably, once a critical level of 
hyperpnoea is reached (suggested to be around 70% of maximum voluntary ventilation 
(MVV) (Brown et al. 2008)) the respiratory muscles engage in significant lactate 
production and release which exceeds net lactate consumption. However, under resting 
conditions there is great capacity for other respiratory and non-respiratory muscles and 
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other tissues to remove lactate from the systemic circulation (i.e. the lactate shuttle) 
(Brooks 1986), which may mask the true influence of respiratory muscle work upon 
[lac
-
]B. Accordingly, we developed a protocol whereby maximal volitional isocapnic 
hyperpnoea was superimposed upon cycling exercise at the maximal lactate steady state 
(MLSS) (Johnson et al. 2006). Since MLSS represents the highest exercise intensity 
associated with equivalence in the rates of blood lactate appearance and clearance, the 
25% increase in [lac
-
]B that resulted from the superimposed hyperpnoea represents a 
truer reflection of net lactate production by the respiratory muscles (Johnson et al. 
2006). However, it remains unknown whether increases in [lac
-
]B during volitional 
hyperpnoea superimposed on exercise are attenuated following IMT. Such an effect 
would be expected if IMT increased the oxidative (Ramirez-Sarmiento et al. 2002) 
and/or lactate transport capacity of the inspiratory muscles (Brown et al. 2008, 2010). 
Training-induced increases in muscle oxidative capacity also elicit alterations in the 
pulmonary oxygen uptake ( 2OV
 ) response to exercise (Jones and Koppo 2005). The 
2OV
  response to square wave exercise above the lactate threshold is sequentially 
characterised by a short (10-20 s) cardiodynamic component (phase I), a primary 
component comprising an exponential increase in 2OV
  over the ensuing 90-180 s 
(phase II), and a 2OV
  slow component describing a continued temporal increase in 
2OV
  (phase III) (Burnley and Jones 2007). The phase II 2OV  kinetics are primarily 
limited by metabolic inertia (Burnley and Jones 2007) and may thus be accelerated by 
an increased intracellular oxygen utilisation due to an IMT-mediated increase in the 
oxidative capacity of the inspiratory muscles; however, this also remains conjecture. 
 
Therefore, the aim of this study was to examine the effects of IMT upon increases in 
[lac
-
]B when volitional hyperpnoea is superimposed upon exercise at MLSS power, and 
2OV
  and [lac-]B kinetics at the onset of exercise. 
 
Methods 
Ethical approval and participants 
Following local ethics committee approval from the host institution 20 healthy non-
smoking, recreationally trained males provided written informed consent to participate 
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in the study (Table 1) which conformed to the standards set by the Declaration of 
Helsinki. Throughout the study participants adhered to their normal training regimen 
and did not engage in any strenuous exercise the day preceding and the day of an 
exercise test. Each participant completed a 24 h diet record prior to their first exercise 
trial, which was then repeated prior to all subsequent trials. Participants abstained from 
alcohol and caffeine in the 24 h prior to testing and arrived at the laboratory 2 h post-
prandial. All trials for each participant were separated by at least 24 h and performed at 
a similar time of day and in similar laboratory conditions (control group pre vs. post: 
temperature: 18.4  3.8 vs. 17.1  2.6 C; relative humidity: 46.8  16.2 vs. 47.7  10.4 
%; IMT group pre vs. post: temperature: 20.2  2.7 vs. 18.3  3.6 C; relative humidity: 
45.4  13.6 vs. 46.2  12.9 %). 
 
Experimental design 
Participants were initially familiarised with all testing procedures and completed 
pulmonary function and maximal inspiratory mouth pressure (MIP) tests. Subsequently, 
following MLSS determination participants were matched for 90% maximal exercise 
minute ventilation ( maxVE
 ), as defined by the highest 30 s average measured during 
the lactate elevation phase of the lactate minimum test (see MLSS determination below), 
and divided equally into an IMT or a control group. Prior to and following a 6 wk 
intervention (IMT or no IMT) participants completed in random order: i) a 30 min 
reference trial at MLSS power, and ii) a 30 min experimental trial at MLSS power 
during which from 20-28 min EV
  and breathing pattern were volitionally matched to 
that commensurate with 90% EV
 max (see Experimental trial below). Cycling cadence 
was displayed upon an electronic display and participants were instructed prior to and 
regularly during all exercise trials to adopt a constant pedal cadence (Brown et al. 
2009). 
 
Pulmonary function and maximal inspiratory mouth pressure 
Pulmonary function was assessed using a pneumotachograph (ZAN 600USB, Nspire 
Health, Oberthulba, Germany) in accordance with published guidelines (ATS/ERS 
2005). A hand-held mouth pressure meter (MicroRPM, Micro Medical, Kent, UK) 
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measured MIP as an index of global inspiratory muscle strength. The mouthpiece 
assembly incorporated a 1 mm orifice to prevent glottic closure during inspiratory 
efforts. Manoeuvres were performed in an upright standing posture, were initiated from 
residual volume, and sustained for at least 1 s (Brown et al. 2008, 2010; Johnson et al. 
2007). A minimum of 5 manoeuvres were performed every 30 s, and this protocol 
continued until 3 consecutive measures differed by no more than 10% or 10 cmH2O 
(whichever was smallest); the highest value recorded was used for subsequent analysis 
(Brown et al. 2008, 2010). MIP was expressed relative to predicted values, as calculated 
using the equation of Wilson et al. (1984): MIPPREDICTED=142-(1.03×age). MIP was 
measured every 2 wk during the intervention. Following IMT, MIP was measured 48 h 
following the final training session and on a separate day to exercise testing. 
 
MLSS determination 
All exercise trials were performed on different days using an electromagnetically braked 
cycle ergometer (Excalibur Sport, Lode, Groningen, The Netherlands). MLSS was 
initially estimated using a previously validated lactate minimum test (Johnson et al. 
2009) comprising three consecutive phases: (i) lactate elevation phase comprising 
maximal incremental exercise; (ii) 8 min recovery phase at 60 W; and (iii) incremental 
phase comprising five 4 min exercise stages at intensities of 45, 50, 55, 60 and 65% of 
the maximum power ( W max) achieved during the lactate elevation phase. During the 
lactate elevation phase power output was increased by 10 W every 15 s so that exercise 
intolerance (cadence <60 revsmin-1) occurred in approximately 10 min. The final power 
defined W max and the highest 2OV  recorded over any 30 s period defined 2OV max. 
During the incremental phase blood samples were taken in the final seconds of each 
stage and the lactate minimum power (estimated MLSS) was calculated as the nadir of a 
2
nd
 order polynomial fitting the [lac
-
]B vs. power data. MLSS was subsequently resolved 
using repeated (typically 2-4) 30 min constant power tests (starting at the lactate 
minimum power) during which [lac
-
]B was determined every 3 min from 15-30 min. 
MLSS was defined as the highest cycling power at which [lac
-
]B did not increase >0.5 
mmol·L
-1
 between 15-30 min of exercise (Aunola and Rusko 1992). If this criterion was 
not satisfied the cycling power for the subsequent 30 min exercise test was, relative to 
the most recent test, changed by 2.5% (4-7 W) depending on the direction of change in 
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[lac
-
]B (Johnson et al. 2009; Johnson et al. 2006; McConnell and Sharpe 2005). The 
precision to which MLSS was determined was based upon previous work (Johnson et 
al. 2009; Johnson et al. 2006; McConnell and Sharpe 2005) and was chosen to ensure 
that a high degree of resolution of MLSS determination was achieved within a relatively 
short (1-2 weeks) time-frame. Following the 6 wk intervention MLSS was re-assessed 
in all participants, starting at the pre-intervention MLSS power and using the same 
criteria and protocol described above.  
 
Reference trial (without volitional hyperpnoea) 
Following a 3 min warm-up at 50% MLSS power participants cycled for 30 min at 
MLSS power. [lac
-
]B was measured at rest and every 2 min during exercise. Blood gases 
were measured every 4 min from 0-20 min and every 2 min thereafter. Breath-by-breath 
respiratory variables were averaged over the final 30 s of every 2 min interval. Every 2 
min heart rate (HR) was measured using short range telemetry (Polar S610, Polar, 
Kempele, Finland) and arterial oxygen saturation (SpO2) was estimated using infrared 
fingertip pulse oximetry (Model 8600, Nonin, Minnesota, USA). Rating of perceived 
exertion for limb discomfort (RPE) was recorded every 2 min using the Borg 6-20 scale. 
Rating of perceived dyspnoea (RPD), where participants were asked to rate their 
breathing “discomfort”, was recorded every 2 min using the modified 0-10 scale (Borg 
1982).  
 
Experimental trial (with volitional hyperpnoea) 
The experimental trial was identical to the reference trial except that from 20-28 min, 
participants volitionally increased EV
  by matching the tidal volume (VT), breathing 
frequency (R) and duty cycle (TI/TTOT) with that commensurate with 90% EV
 max. 
Pilot work from our laboratory indicated that 90% EV
 max was the highest value that 
could be maintained in a square wave fashion for 8 min whilst exercising at MLSS 
power. An audio metronome paced R and real-time visual feedback of EV
  and VT were 
provided (Brown et al. 2008). Following volitional hyperpnoea participants resumed a 
spontaneous breathing pattern for the final 2 min of exercise. The volitional hyperpnoea 
protocol was similar to that used previously by our group (Brown et al. 2008; Johnson 
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et al. 2006) and was designed to mimic the breathing pattern of high-intensity whole 
body exercise. 
 
Six week intervention  
The IMT group performed 30 consecutive dynamic inspiratory efforts twice daily for 6 
wks using an inspiratory pressure-threshold device (POWERbreathe
® 
Classic series 1
st
 
generation, Gaiam, UK). The initial training load was 50% MIP. Participants were 
encouraged to periodically increase the training load to accommodate improvements in 
MIP, such that task failure was reached at around the 30
th
 inspiratory effort. 
Measurement of MIP at 2 wk intervals permitted the threshold load of the device to be 
objectively increased by the researchers to ensure the training load was equal to 50% 
MIP. Each inspiratory effort was initiated from residual volume and participants strove 
to maximise VT. This protocol is known to be effective in eliciting an adaptive response 
(Brown et al. 2008, 2010; Johnson et al. 2007; McConnell and Sharpe 2005). All 
participants recorded habitual training in a training diary, and the IMT group also 
recorded IMT adherence. The control group continued with their habitual training 
schedule and were not exposed to an intervention. A placebo treatment was not applied 
to the control group since the study outcome measures, including MLSS power 
(McConnell and Sharpe 2005) and blood-borne parameters, (Brown et al. 2008, 2010) 
could not be influenced by either motivation or expectation. Participants were informed 
that they belonged to a control group following the determination of MLSS and to avoid 
any possible disadvantage were afforded the opportunity to undertake IMT upon 
completion of the study. 
 
Blood sampling and respiratory measurements 
Arterialised venous blood was drawn from a dorsal hand vein via an indwelling 21-G 
cannula. Arterialisation was ensured by immersing the hand in ~40˚C water for 10 min 
prior to cannulation and by warming the hand during exercise using an infrared lamp. 
Blood samples were drawn into a 2 ml pre-heparinised syringe (PICO 50, Radiometer, 
Copenhagen, Denmark) and analysed immediately (ABL520, Radiometer, Copenhagen, 
Denmark) for the partial pressure of carbon dioxide (PCO2) and pH, which were 
corrected for changes in rectal temperature (Squirrel 2020, Grant Instruments, 
9 
 
Cambridge, UK). [lac
-
]B was determined using an automated enzymatic method 
(Biosen, EKF Diagnostics, Barleben, Denmark). Plasma bicarbonate concentration 
( ][HCO3
 ) and base excess of the extracellular fluid (BEECF) were calculated using the 
Henderson-Hasselbalch and Siggaard-Anderson equations, respectively (for equations 
see: Brown et al. 2008). 
 
Respiratory variables were measured breath-by-breath (ZAN 600USB, Nspire Health, 
Oberthulba, Germany). Subjects wore a facemask (model 7400, Hans Rudolph, KS, 
USA) connected to a flow pneumotachograph and, distally, a two-way non-rebreathing 
valve (model 2730, Hans Rudolph, Missouri, USA) onto which a 1.5 m length of wide-
bore tubing was connected to the inspiratory port. During volitional hyperpnoea CO2 
was added into this tubing to increase FICO2 and retain end-tidal and, consequently, 
arterialised blood PCO2 at levels commensurate with steady state exercise (Brown et al. 
2008; Johnson et al. 2006). The addition of CO2 into the inspiratory line adversely 
affected the ability of the breath-by-breath analyser to accurately measure 2COV
 , and 
thus RER, during volitional hyperpnoea, thus these data are not presented over 22-28 
min.  
 
Data and statistical analyses 
Pulmonary 2OV
  kinetics  
The pulmonary 2OV
  response to exercise was modelled using a single mono-
exponential model (Burnley et al. 2001). Breath-by-breath data were linearly 
interpolated to provide second by second values following the elimination of outlying 
breaths defined as those  4 SD of the local mean (Lamarra et al. 1987). Because each 
participant performed two square wave transitions from 3 min cycling at 50% MLSS 
power to 20 min cycling at 100% MLSS power (i.e. 0-20 min during the reference and 
experimental trials), the two trials were time aligned and averaged to improve the signal 
to noise ratio. This provided for each participant one set of second by second data for 
the pre- and post-intervention trials. The amplitude and time delay of the primary (phase 
II) 2OV
  response were modelled following a 20 s time delay (Ozyener et al. 2001) to 
exclude the cardiodynamic component (phase I): 
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)e(1AOV)(OV TD)/(1b2,2
τtt    
where )(OV 2 t
  (L·min-1) is the 2OV  for a given time (t; min); b,2OV
  is the baseline 
2OV
  (L·min-1) measured during the final minute of the warm-up preceding the onset of 
exercise; A1 (L·min
-1
) is the amplitude of the exponential curve and defined as the 
increase in 2OV
  from b,2OV  to the end of phase II; and τ  (s) and TD (s) are the time 
constant and time delay, respectively. The amplitude of the 2OV
  slow component 
(phase III; A2) was defined as the difference in 2OV
  between TD (end of phase II) and 
that measured during the final 30 s of the 20 min period (Burnley et al. 2001). 
 
Blood lactate kinetics 
The [lac
-
]B response to exercise was modelled using a single mono-exponential function 
(Beneke 2003). For each participant the [lac
-
]B measured during the reference and 
experimental trials (from 0-20 min only; i.e. excluding volitional hyperpnoea) were time 
aligned and averaged, thus producing one set of [lac
-
]B against time data per-participant 
for pre- and post-intervention comparisons: 
 te1ALa(0))La(  t  
where La(t) (mmol·L
-1
) is the [lac
-
]B for a given time (t; min); La(0) (mmol·L
-1
) is the 
[lac
-
]B at the onset of exercise; and A (mmol·L
-1
) and τ (s) are the amplitude, defined as 
the increase in [lac
-
]B from La(0) to steady state (where Δ[lac
-
]B/Δt = 0), and the time 
constant of the response, respectively.  
 
Statistical analysis 
In order to compare the discrete physiological responses between steady state exercise 
and volitional hyperpnoea, the reference and the experimental trials were averaged and 
analysed over two time periods: a steady state period from 12-20 min (as it takes 
approximately 12 min to reach a steady state in [lac
-
]B) and a volitional hyperpnoea 
period from 22-28 min (Johnson et al. 2006). Pre- and post-intervention results and 
group interactions were assessed using one-way or two-way ANOVA with repeated 
measures and Tukey’s HSD post-hoc analysis. Interactions were defined for “group” 
(IMT vs. control), “trial” (reference [without hyperpnoea] vs. experimental [with 
hyperpnoea]) and “time” (12-20 min [steady state period] or 22-28 min [volitional 
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hyperpnoea period]). Pearson product-moment correlation coefficients were calculated 
to assess the relationship between selected variables. A-priori α was set at P0.05. 
Results are presented as mean  SD. All mathematical modelling was performed using 
commercially available software (GraphPad Prism Version 5.01, GraphPad software, 
Inc. CITY, USA). Statistical analysis was performed using SPSS for Windows (SPSS, 
Chicago, Illinois, USA). 
 
Results 
With the exception of age and predicted MIP and MVV10, there were no between group 
differences in any variable prior to the intervention and all responses remained 
unchanged in the control group following the intervention. 
 
Inspiratory muscle strength  
Baseline pulmonary function and MIP were within normal limits (Table 1). Training 
compliance was excellent in the IMT group (96  4% of training sessions completed). 
Inspection of training diaries revealed habitual training remained constant in both 
groups. MIP was unchanged in the control group following the intervention period (pre 
vs. post: 149  25 vs. 147  27 cmH2O). Conversely, MIP increased in the IMT group 
from 164  23 cmH2O at baseline to 174  24 (P<0.05), 187  23 (P<0.01) and 194  
21 cmH2O (+19%) (P<0.01) following 2, 4 and 6 wks, respectively. Baseline absolute 
MIP was negatively correlated with the relative IMT-mediated increase in MIP (r=-
0.79, P<0.05), but not the absolute IMT-mediated increase in MIP (r=-0.464, P=0.177). 
 
MLSS power 
With the exception of one control participant in whom MLSS power decreased by 2.5% 
(-7 W) MLSS power was unchanged following the intervention in both groups. MLSS 
power was 210  27 and 210  27 W pre- and post-IMT, respectively, and 205  29 and 
204  27 W in the control group pre- and post-intervention, respectively. 
 
Respiratory responses to MLSS and volitional hyperpnoea  
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Volitional hyperpnoea was 90.3  9.6% EV
 max (76  19% MVV10) in the IMT group 
and 91.2  4.9% EV
 max (81  15% MVV10) in the control group (for absolute EV , 
2OV
  and 2COV  see Figure 1 and Tables 2 and 3). EV  and breathing pattern during 
both the reference and the experimental trials were not different between groups before 
or after the intervention period. 2OV
 , 2COV  and RER throughout the reference trial 
and 2OV
  and 2COV  throughout the experimental trial were not different between 
groups and remained unchanged following the intervention (Tables 2 and 3). Therefore 
the breathing challenge was repeated with considerable accuracy following the 
intervention (see Figure 1). Parameters of the pulmonary 2OV
  response to exercise are 
shown in Table 4. A ~14 s reduction in τ1 was observed after IMT (group × time 
interaction, P<0.05); all other parameters of the 2OV
  response to exercise remained 
unchanged following the intervention in both groups. The reduction in τ1 following IMT 
was not correlated with the absolute (r=-0.014, P=0.974) or relative (r=0.206, P=0.625) 
change in baseline MIP following IMT. 
 
Blood lactate concentration 
Before IMT the MLSS [lac
-
]B was 3.7   1.8  mmol·L
-1 
in the reference trial (12-30 min) 
and 4.0   2.2  mmol·L-1 (12-20 min) in the experimental trial. After IMT [lac-]B over 
12-30 min during the reference trial was reduced (main effect trial, P<0.05) by 0.7   
1.7  mmol·L
-1
 (-8%) and over 12-20 min of the experimental trial by 0.9   1.8  
mmol·L
-1
 (-15%) (main effect trial, P<0.05) (Figure 2). Furthermore, the amplitude (A) 
of the increase in [lac
-
]B at the onset of exercise, plateau in MLSS [lac
-
]B (where Δ[lac
-
]B/Δt=0) and the time constant () of the increase in [lac
-
]B from exercise onset to the 
plateau in MLSS [lac
-
]B (i.e. the steady state) were reduced after IMT (P<0.05) (Table 
5). 
 
Before IMT volitional hyperpnoea caused a 1.0   0.6  mmol·L-1 (27%) increase in [lac-
]B (relative to 12-20 min) (P<0.05). After IMT the increase in [lac
-
]B was abolished 
(Figure 2), thus at 30 min, [lac
-
]B was 1.8   1.3  mmol·L
-1 
(-26%) lower than that 
measured during the pre-IMT experimental trial (group × trial × time interaction; 
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P<0.01). Both the absolute (r=0.75, P<0.05) and relative (r=0.66, P<0.05) increases in 
baseline MIP following IMT were correlated with the absolute reduction in [lac
-
]B 
observed at min 30 of the experimental trial (Figure 3). 
 
Acid-base balance 
Temporal changes in acid-base balance for the IMT group are shown in Figure 4. 
Volitional hyperpnoea increased [H
+
] (P<0.05) and this response was unchanged 
following IMT. From 22-28 min of the reference trial there was a trend (P=0.07) for 
[H
+
] to be lower after IMT.  
 
Approximately 10 min following the onset of exercise ][HCO3
  and BEECF remained 
constant with time during the pre-intervention reference trial in both groups. After IMT 
and during the reference trial BEECF was greater from 22-28 min (trial × time 
interaction; P<0.05). Prior to the intervention volitional hyperpnoea caused a reduction 
in ][HCO3
  and BEECF (P<0.05) in both groups by 30 min, and these responses were 
unchanged in the control group following the intervention. Conversely, following IMT 
the reductions in [HCO3
-
] and BEECF during volitional hyperpnoea were attenuated (trial 
× time interaction; P<0.05; Figure 4).  
 
PCO2 was similar between groups and between trials prior to and following the 
intervention (Figure 4). PCO2 during volitional hyperpnoea and over the equivalent time 
period of the reference trial was not different, thus isocapnia was maintained 
successfully throughout volitional hyperpnoea.  
 
Heart rate and arterial oxygen saturation 
Over 12-20 min of the pre-IMT reference trial, HR (145  11 beatsmin-1) and SpO2 
(95.3  1.2%) were not different from that measured over 12-20 and 22-28 min of all 
other trials, except the volitional hyperpnoea period during the experimental trials 
(Tables 2 and 3). Specifically, prior to the intervention in the IMT group HR increased 
during volitional hyperpnoea to 160  15 beatsmin-1 (P<0.05); this increase was 
attenuated following IMT (157  14 beatsmin-1) (trial × time interaction, P<0.05). 
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Before IMT the SpO2 over 12-20 min of the experimental trial was 94.6  1.3% and 
increased to 95.8  1.2% during volitional hyperpnoea (P<0.05), which was unchanged 
following IMT (Tables 2 and 3).  
 
Perceptual responses 
There were no differences between groups for RPD measured during the reference trial 
prior to and following the intervention. Similarly, prior to the intervention there were no 
differences between groups for RPD measured over 12-20 min of the experimental trial 
(see Tables 2 and 3 for data from the IMT group). During volitional hyperpnoea (22-28 
min), RPD increased significantly in both groups (P<0.05) and this response was 
unchanged following the intervention in the control group. Conversely, after IMT, RPD 
during volitional hyperpnoea was lower by 1.6  1.8 AU (trial × time interaction, 
P<0.05, Table 3). RPE responses during the reference trial were unchanged in both 
groups following the intervention. RPE responses during the experimental trial were 
also unchanged in the control group following the intervention. Conversely, following 
IMT, RPE during the experimental trial was lower over 12-20 min (12.7  0.9 vs. 11.7  
1.1, P<0.05) and 22-28 min (13.1  1.4 vs. 12.0  1.0, P=0.07) . 
 
Discussion 
The novel finding of this study was that 6 wks of IMT abolished the increase in [lac
-
]B 
observed when volitional hyperpnoea was superimposed on cycling exercise at the 
MLSS power. IMT also attenuated the accompanying volitional hyperpnoea-induced 
increases in RPD, HR and acid-base disturbance. We have also demonstrated for the 
first time accelerated [lac
-
]B kinetics and, in agreement with a previous study (Bailey et 
al. 2010), accelerated 2OV
  kinetics at the onset of exercise following IMT.  
 
The increase in [lac
-
]B observed when volitional hyperpnoea was superimposed on 
exercise is consistent with previous studies in which the breathing challenge was 
performed during exercise (Johnson et al. 2006) or at rest (Brown et al. 2008; Verges et 
al. 2007). The 25% increase in [lac-]B caused by the relatively modest (60 Lmin
-1
) 
increase in EV
  during volitional hyperpnoea suggests that the respiratory muscles were 
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contributing to systemic lactate exchange. In contrast, despite a larger absolute increase 
in EV
  (100 Lmin-1) Babcock et al. (1995) failed to observe an increase in [lac-]B 
during 4.5 min of volitional hyperpnoea performed at rest, although a greater lactate 
clearance capacity under resting conditions (Brooks 1986) and the brevity of the 
breathing challenge may have precluded measurable changes in [lac
-
]B (Brown et al. 
2008). Spengler et al. (2000) also failed to observe an increase in [lac
-
]B during 43 min 
of volitional isocapnic hyperpnoea performed at rest. However, further to the limitations 
associated with volitional hyperpnoea performed at rest (see above), the EV
  (122 
Lmin-1, 62% of MVV) was probably below the critical level (around 70% MVV 
(Brown et al. 2008)) at which the respiratory muscles engage in significant lactate 
production and release. Nevertheless, a limitation of the present study was that the work 
of breathing specifically associated with exercise hyperpnoea, i.e. the pressure-volume 
characteristics of each breath (Babcock et al. 1995), was not mimicked. Therefore, since 
the work of breathing (particularly that associated with expiration) during volitional 
hyperpnoea exceeds that associated with an identical, spontaneous EV
  during exercise 
(Klas and Dempsey 1989), the net increase in respiratory muscle lactate production in 
our experimental condition may overestimate that of exercise. Conversely, it is also 
possible that the increased [lac
-
]B during volitional hyperpnoea superimposed on 
exercise may have been partially countered by an increase in lactate consumption by 
highly oxidative respiratory muscles. Nonetheless, our primary and novel finding that 
the volitional hyperpnoea-mediated increase in [lac
-
]B was abolished following IMT is a 
stark illustration of the inspiratory muscles’ plasticity and capacity to affect systemic 
blood chemistry.  
 
Our findings suggest that following IMT the relative work performed by the inspiratory 
muscles during volitional hyperpnoea was reduced (due to the 19% increase in 
inspiratory  muscle strength) resulting in a reduction in net lactate production (Brown et 
al. 2008; Johnson et al. 2006). Hypertrophy of the diaphragm (Downey et al. 2007) and 
external intercostals (Ramirez-Sarmiento et al. 2002) may have decreased the relative 
work performed by the inspiratory muscles, thus reducing/delaying the recruitment of 
less efficient, lactate producing inspiratory muscle fibres (Marcinik et al. 1991). 
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Moderate intensity, high repetition strength training may also increase type I muscle 
fibre prevalence, mitochondrial enzyme activity (Sale et al. 1990), and expression of 
sarcolemmal and mitochondrial membrane-bound monocarboxylate transporters (Juel et 
al. 2004), thus promoting reduced production/increased clearance of lactate. 
Intriguingly, an increased prevalence of type I fibres and oxidative enzymes has been 
observed in the external intercostals of COPD patients following 5 wks of IMT 
(Ramirez-Sarmiento et al. 2002).  
 
An alternative/additional explanation for our findings is that prior to IMT the increased 
[lac
-
]B during volitional hyperpnoea was, in part, due to reduced locomotor muscle 
blood flow secondary to a respiratory muscle metaboreflex (Dempsey et al. 2006). The 
latter is activated by the accumulation of fatigue-related metabolites, which stimulate 
respiratory muscle metaboreceptors, thus promoting sympathetically-mediated 
vasoconstrictor outflow. A reduction in locomotor muscle perfusion may have resulted 
in increased type II motor unit recruitment within the locomotor muscles, thus 
promoting greater lactate production and less lactate clearance by leg muscle. Following 
IMT, an attenuation of metabolite accumulation in the inspiratory muscles (Brown et al. 
2008, 2010) may have blunted the inspiratory muscle metaboreflex (Witt et al. 2007) 
thereby preserving locomotor muscle blood flow and attenuating the impact of 
locomotor muscle on [lac
-
]B. However, this notion is challenged by the observation of 
an unchanged arterial-femoral venous [lac
-
]B despite (relative to a control trial) an 11% 
change in leg blood flow due to 50% change in the work of breathing during maximal 
exercise (Harms et al. 1997).  
 
The IMT-mediated decrease in the MLSS [lac
-
]B, without a corresponding change in 
MLSS power, concurs with previous findings (McConnell and Sharpe 2005), and may 
be related, in part, to the reduced phase II time constant of the pulmonary 2OV
  kinetics. 
There is growing evidence that the respiratory muscles per se may influence 2OV
  
kinetics. Specifically, low intensity inspiratory muscle loading (15 cmH2O) increases 
the phase II 2OV
  time constant (Keslacy et al. 2005), and the 2OV  slow component 
during heavy exercise is partly explained (up to 24%) by the increased EV
  (Candau et 
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al. 1998). Furthermore, the 2OV
  slow component is increased with inspiratory muscle 
loading (15 cmH2O) (Carra et al. 2003) and decreased with unloading (heliox breathing) 
(Cross et al. 2010). Recently, 4 wks of IMT was shown to reduce the 2OV
  slow 
component during severe and maximal, but not moderate, intensity exercise (Bailey et 
al. 2010), although despite a shorter overall time constant for 2OV
 , the phase II time 
constant was unchanged. This discrepancy with the present study could be due, in part, 
to between-study differences in IMT duration (4 wks in Bailey et al. vs. 6 wks in the 
present study). Specifically, although the 17% increase in MIP observed by Bailey et al. 
(2010) was similar to the 19% increase observed in the present study, increased MIP per 
se is not correlated with changes in 2OV
  kinetics (present study; Bailey et al. 2010) or 
performance enhancement (Griffiths and McConnell 2007; Johnson et al. 2007). 
Conversely, we suggest that changes in physiological responses to exercise following 
IMT are largely the result of IMT-mediated increases in the oxidative capacity of the 
inspiratory muscles (see below), and that the additional 28 IMT sessions performed in 
the present study (compared to Bailey et al. 2010) resulted in greater inspiratory muscle 
adaptation (Henriksson 2000; Staron et al. 1994), as reflected, in part, by the reduced 
phase II time constant.   
 
A reduced phase II 2OV
  time constant is commonly observed, albeit to a greater extent 
(up to 50%) following whole-body endurance training (Burnley and Jones 2007). This is 
attributed to increased intracellular oxygen utilisation (i.e. reduced metabolic inertia) 
most likely due to an increased prevalence of type I muscle fibres and increased 
intracellular-oxidative enzyme activity (Jones and Koppo 2005). These adaptations may 
well occur within the inspiratory muscles following IMT, thus reducing metabolic 
inertia within the inspiratory muscles. Consequently, increased lactate utilsisation by 
inspiratory muscles at exercise onset (which is also likely to be magnified by the greater 
expression of membrane-bound lactate transport proteins) may “reset” the MLSS [lac-]B 
without modifying the MLSS power. Such adaptations may also explain the attenuated 
metabolic acidosis associated with both exercise and volitional hyperpnoea (see Figure 
4). Improved 2OV
  dynamics have also been linked with increased exercise tolerance 
(Burnley and Jones 2007), thus faster phase II 2OV
  kinetics, and hence reduced oxygen 
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deficit, may partly explain our previous observation of an IMT-mediated increase in 
“anaerobic work capacity” and hence cycling time trial performance (Johnson et al. 
2007).  
 
The 30% reduction in RPD during volitional hyperpnoea following IMT concurs with 
observations made during whole body exercise (Romer et al. 2002a; Volianitis et al. 
2001) and isolated breathing challenges (Verges et al. 2007; Verges et al. 2009). Whilst 
the breathing challenge was identical following IMT the lower relative load on the 
inspiratory muscles, due to a greater force generating capacity (i.e. increased MIP), may 
have reduced central corollary discharge for a given EV
  (Redline et al. 1991). Repeated 
IMT bouts may also alter mechanosensitive type III and chemosensitive type IV nerve 
afferents within the inspiratory muscles (Sinoway et al. 1996), thus also reducing 
ascending afferent feedback from the inspiratory muscles. These changes may elicit 
performance benefits as during heavy exercise with high EV
  reduced dyspnoea due to 
IMT is correlated with increased exercise tolerance (Romer et al. 2002b).  
 
Finally, IMT also attenuated the increase in HR during volitional hyperpnoea which is 
consistent with observations made during fatiguing resistive inspiratory muscle loading 
performed whilst at rest (Witt et al. 2007). Although repeated mechanical deformations 
of the inspiratory muscles during IMT may desensitise mechanically sensitive type III 
afferents (Sinoway et al. 1996), Witt et al. (2007) argue that an IMT-mediated reduction 
in HR is primarily due to an increased oxidative capacity of the inspiratory muscles, 
which attenuates metabolite accumulation within the inspiratory muscles, thereby 
reducing phrenic afferent discharge of both type III and IV nerve endings. The lower 
[lac
-
]B and attenuated disturbance in acid-base balance during volitional hyperpnoea 
following IMT observed in the present study supports this notion.   
 
In conclusion, increases in [lac
-
]B when volitional hyperpnoea was superimposed on 
exercise at MLSS power were abolished following 6 wks of IMT. Furthermore, IMT 
resulted in faster phase II 2OV
  and [lac-]B kinetics at the onset of exercise and a lower 
MLSS [lac
-
]B. Although the precise mechanisms underpinning these changes remain 
unknown, there is mounting evidence supporting an IMT-mediated increase in the 
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oxidative and/or lactate transport capacity of the inspiratory muscles. The relevance of 
these findings are twofold: firstly, we have further illustrated that the trained inspiratory 
muscles have a significant effect upon systemic lactate and pulmonary 2OV
  kinetics; 
and secondly, that these mechanisms may explain, in part, the improvements in whole 
body exercise tolerance noted in previous studies following specific IMT. 
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Table 1. Descriptive characteristics of the participants. Values are mean  SD. 
 Control (n=10) IMT (n=10) 
Age (years) 25.9  4.8 36.7  6.1 * 
Body mass (kg) 77.8  10.0 84.8  13.9 
Height (cm) 180.8  8.4 179.4  7.1 
FVC (L) 5.79  1.14 (107  15) 5.41  0.88 (108  11) 
FEV1 (L) 4.47  0.91 (99  15) 4.13  0.65 (100  14) 
FEV1/FVC (%)  78  7 (92  7) 77  6 (94  8) 
MVV10 (L∙min
-1
)  188  25 (100  13) 206  39 (119  23) 
MIP (cmH2O) 149  25 (115  5) 164  23 (104  6) 
EV
 max (L∙min-1) 149  19 150  19 
2OV
 max (L∙min-1) 3.82  0.41 4.09  0.66 
2OV
 max  
(mL∙kg-1·min-1) 
49.4  4.9 48.8  8.0 
maxW (W) 366  37 393  47 
   
FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; MVV10, maximal 
voluntary ventilation in 10 s; MIP, maximal inspiratory mouth pressure; maxVE
 , 
maximal exercise minute ventilation; 2OV
 max, maximal oxygen consumption; 
W max, maximal power output. Values in parenthesis show percent of predicted values 
(ATS/ERS 2005; Wilson et al. 1984). *Different from control group (P<0.05). 
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Table 2. Physiological responses to 30 min cycling exercise during the reference trials 
pre- and post-IMT. Values are mean  SD. 
 
 Pre-IMT Post-IMT 
 12-20 min 22-28 min 12-20 min 22-28 min 
EV
 (Lmin-1) 67  9 71  9 72  7 76  10 
2OV
 (Lmin-1) 2.55  0.39 2.55  0.42 2.81  0.33 2.81  0.37 
2COV
 (Lmin-1) 2.46  0.41 2.54  0.43 2.76  0.28 2.78  0.36 
RER 1.08  0.02 0.99  0.03 0.96  0.03 0.96  0.04 
HR (beatsmin-1) 145  11 152  14 148  11 153  12 
SpO2 (%) 95.3  1.2 95.3  1.0 94.8  1.1 94.7  1.2 
†
 
RPE (AU) 12.1  0.7 12.8  0.9* 11.7  1.5 12.5  2.1* 
RPD (AU) 2.9  0.6 3.1  0.9 2.8  0.7 3.1  0.6* 
* P<0.01 vs. 12-20 min; † P<0.05 vs. pre; § P<0.05 trial × time interaction; AU, 
arbitrary units. Pre-IMT and post-IMT define the responses observed prior to and 
following a 6 wk inspiratory muscle training (IMT) intervention period. Data from the 
control group both prior to and following the intervention not shown since they were 
not different from pre-IMT. 
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Table 3. Physiological responses to 30 min cycling exercise during the experimental 
trials pre- and post-IMT. Values are mean  SD. 
 
 Pre-IMT Post-IMT 
 12-20 min 22-28 min 12-20 min 22-28 min 
EV
 (Lmin-1) 71.9  7.0 134.2  13.8* 72.9  6.6 131.1  14.8* 
2OV
 (Lmin-1) 2.82  0.24 3.28  0.43* 2.83  0.30 3.25  0.47* 
2COV
 (Lmin-1) 2.70  0.28 - 2.68  0.26 - 
RER 0.95  0.05 - 0.95  0.08 - 
HR (beatsmin-1) 152  12 160  15* 149  11 157  14*§ 
SpO2 (%) 94.6  1.3 95.8  1.2* 94.6  1.4 95.9  1.3* 
RPE (AU) 12.7  0.9 13.1  1.4 11.7  1.1 12.0  1.0 
RPD (AU) 3.2  0.4 5.6  1.5* 2.9  0.7 4.0  1.4*†§ 
* P<0.01 vs. 12-20 min; † P<0.05 vs. pre; § P<0.05 trial × time interaction; AU, 
arbitrary units. 2COV
  and RER data not shown from 22 to 28 min of experimental trial 
due to technical limitations. Pre-IMT and post-IMT define the responses observed prior 
to and following a 6 wk inspiratory muscle training (IMT) intervention period. Data 
from the control group both prior to and following the intervention not shown since they 
were not different from pre-IMT. 
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Table 4.  Pulmonary 2OV
  kinetics response to exercise. Values are mean  SD. 
 Control  IMT 
 Pre Post  Pre Post 
Phase II      
TD1 (s) 15.9  4.8 13.0  10.5  15.7  4.2 16.3  4.4 
A1 (L·min
-1
) 0.94  0.36 1.02  0.19  0.91  0.26 0.86  0.25 
τ1 (s) 56.1  61.0 51.6  18.6  45.2  13.8 31.3  18.4 
†§
 
Phase III       
A2 (L·min
-1
) 1.89  0.32 1.81  0.34  1.83  0.31 1.94  0.30 
TD1, time delay of the phase II response; A1, amplitude of the phase II response; 1τ , 
time constant of the phase II response; A2, amplitude of the phase III response (slow 
component). Pre and post define the responses observed prior to and following a 6 wk 
intervention period. * 
†
 Different from pre-intervention (P<0.05); 
§
 group × time 
interaction (P<0.05).  
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Table 5. Blood lactate kinetics during exercise. Values are mean  SD. 
 Control  IMT 
 Pre Post  Pre Post 
La(0) (mmol·L
-1
 ) 1.0  0.3 0.9  0.3  1.0  0.1 0.9  0.2 
A (mmol·L
-1
 ) 3.1  1.7 3.7  1.8  3.1  2.2 2.2  1.3* † 
τ  (s) 3.8  1.1 3.9  1.2  4.1  1.4 2.9  1.3* 
†
 
MLSS [lac
-
]B (mmol·L
-1
) 4.1  1.8 4.5  1.9  4.1  2.2 3.1  1.4* † 
La(0), [lac
-
]B at exercise onset; A, amplitude of response; τ , time constant of response. 
Pre and post define the responses observed prior to and following a 6 wk intervention 
period. * 
†
 Different from pre-intervention (P<0.05). 
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Figure Legends 
 
Figure 1. Pre-IMT breathing pattern during the reference and experimental trials. Data 
post-IMT and pre- and post-intervention in the control group not shown since they were 
not different from the data illustrated above. Time 0 min reflects the end of a 3 min 
warm-up at 50% MLSS power. Values are mean  SD. *Different from steady state 
period (12-20 min) (P<0.01).  
 
Figure 2. Blood lactate concentration ([lac
-
]B) during the reference and experimental 
trials for the IMT group only. Pre- and post-intervention data for the control group were 
not different from pre-IMT. Time 0 min reflects the end of a 3 min warm-up at 50% 
MLSS power. Values are mean  SD. *Different from steady state period (12-20 min) 
(P<0.05); 
†
post-IMT experimental trial different from pre-IMT experimental trial 
(P<0.05).  
 
Figure 3. Relationship between the absolute (left panel) and relative (right panel) IMT-
induced change in MIP and the reduction in [lac
-
]B at 30 min during the experimental 
trials. 
 
Figure 4. Pre- and post-IMT acid-base parameters. Data pre- and post-intervention in 
the control group not shown since they were not different from pre-IMT. Time 0 min 
reflects the end of a 3 min warm-up at 50% MLSS power. Values are mean  SD. § trial 
× time interaction for post-IMT reference trial (P<0.05); 
† 
post-IMT experimental trial 
different from pre-IMT experimental trial (P<0.05); 
§§ 
trial × time interaction for post-
IMT experimental trial (P<0.05).  
 
 
